These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2670599)

  • 1. Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures.
    Clifford DB; Zorumski CF; Olney JW
    Exp Neurol; 1989 Sep; 105(3):272-9. PubMed ID: 2670599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.
    Clifford DB; Olney JW; Benz AM; Fuller TA; Zorumski CF
    Epilepsia; 1990; 31(4):382-90. PubMed ID: 2196169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of N-methylaspartate and synaptic responses of neurones in the rat ventrobasal thalamus by ketamine and MK-801.
    Salt TE; Wilson DG; Prasad SK
    Br J Pharmacol; 1988 Jun; 94(2):443-8. PubMed ID: 3293684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats.
    Trommer BL; Pasternak JF
    Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal cortical seizures cause distant thalamic lesions.
    Collins RC; Olney JW
    Science; 1982 Oct; 218(4568):177-9. PubMed ID: 7123229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
    Sharma AC; Thorat SN; Nayar U; Kulkarni SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):111-6. PubMed ID: 1838740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of non-competitive NMDA receptor antagonists on rats exposed to hyperbaric pressure.
    Wardley-Smith B; Wann KT
    Eur J Pharmacol; 1989 Jun; 165(1):107-12. PubMed ID: 2548878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.
    Mansbach RS; Geyer MA
    Neuropsychopharmacology; 1989 Dec; 2(4):299-308. PubMed ID: 2692589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.
    Ormandy GC; Jope RS; Snead OC
    Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC
    Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.